AAAAAA

   
Results: 1-8 |
Results: 8
Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells
Authors: Balla-Jhagjhoorsingh, SS Mooij, P ten Haaft, PJF Bogers, WMJM Teeuwsen, VJP Koopman, G Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, J INFEC DIS, 184(2), 2001, pp. 136-143
Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells
Authors: Balla-Jhagjhoorsingh, SS Mooij, P ten Haaft, PJF Bogers, WMJM Teeuwsen, VJP Koopman, G Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, AM NATURAL, 158(2), 2001, pp. 136-143
Developments in preclinical AIDS vaccine efficacy models
Authors: Bogers, WMJM Cheng-Mayer, C Montelaro, RC
Citation: Wmjm. Bogers et al., Developments in preclinical AIDS vaccine efficacy models, AIDS, 14, 2000, pp. S141-S151
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy
Authors: Mooij, P Bogers, WMJM Oostermeijer, M Koornstra, W Ten Haaft, PJF Verstrepen, BE Van der Auwera, G Heeney, JL
Citation: P. Mooij et al., Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy, J VIROLOGY, 74(9), 2000, pp. 4017-4027
Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
Authors: Rosenwirth, B ten Haaft, P Bogers, WMJM Nieuwenhuis, IG Niphuis, H Kuhn, EM Bischofberger, N Heeney, JL Uberla, K
Citation: B. Rosenwirth et al., Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques, J VIROLOGY, 74(4), 2000, pp. 1704-1711
An anti-HIV strategy combining chemotherapy and therapeutic vaccination
Authors: Rosenwirth, B Bogers, WMJM Nieuwenhuis, IG Ten Haaft, P Niphuis, H Kuhn, EM Bischofberger, N Erfle, V Sutter, G Berglund, P Liljestrom, P Uberla, K Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques
Authors: Lehner, T Wang, YF Doyle, C Tao, L Bergmeier, LA Mitchell, E Bogers, WMJM Heeney, J Kelly, CG
Citation: T. Lehner et al., Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques, EUR J IMMUN, 29(8), 1999, pp. 2427-2435
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees
Authors: Bogers, WMJM Koornstra, WH Dubbes, RH ten Haaft, PJF Verstrepen, BE Jhagjhoorsingh, SS Haaksma, AGM Niphuis, H Laman, JD Norley, S Schuitemaker, H Goudsmit, J Hunsmann, G Heeney, JL Wigzell, H
Citation: Wmjm. Bogers et al., Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees, J GEN VIROL, 79, 1998, pp. 2895-2903
Risultati: 1-8 |